[Alert] Even BRIEF exposure to this cancer treatment could prove DEADLY
I can’t think of anything worse.
You’re diagnosed with cancer… you put your faith into your cancer doc…
And the treatment he gives you puts you in the crosshairs for ANOTHER type of cancer.
It sounds like a nightmare…
But according to the latest research, it’s not just POSSIBLE.
It’s HAPPENING.
Frankly, I’d be stunned… if this were the FIRST time a cancer therapy was linked to the development of new cancer.
But it’s NOT.
Here’s the latest you need to know about.
2X the cancer risk… after just DAYS
I’ve shared with you before how chemo treatments can increase the risk of certain types of blood cancer within 5 years.
And according to the National Cancer Institute’s 2018 study, that’s not just for one type of solid tumor.
In fact, that rings true for ALL BUT one type of solid tumor!
The scary part is that it’s that second cancer that can KILL you.
Well, the latest has to do specifically with ovarian cancer… and the class of drugs used to treat it, called PARP inhibitors.
Now, these drugs are pretty new – the first one was approved just over 6 years ago.
And, as with many FDA-approved drugs, we’re STILL finding out exactly what the dangers are.
This one’s a doozy.
Looking at 18 randomized clinical trials, the researchers of a recently-published review out of France found that PARP inhibitors could more than DOUBLE the risk of 2 different types of blood cancers!
I’m talking about acute myeloid leukemia (AML)… which starts in the bone marrow and can quickly spread to your lymph nodes, central nervous system, and vital organs…
As well as a common precursor of AML, known as myelodysplastic syndrome (MDS).
MDS strikes a majority of patients over the age of 60… and can require a bone marrow transplant.
You don’t want to mess with EITHER of these blood cancers.
In fact, the meta-analysis shows that nearly HALF of the patients DIED after developing either AML or MDS.
Now, your doc may tell you that statistics show improved survival rates in certain ovarian cancer patients who take a PARP inhibitor…
But he could be playing with fire!
Because YEARS of exposure to the drug aren’t necessary to increase the secondary cancer risk.
The SHORTEST duration of PARP exposure recorded was LESS THAN A WEEK!
And it turns out that blood cancer might not take very long to get you in its clutches.
The French researchers found that the “latency” period from the first dose of a PARP inhibitor to the detection of a blood cancer could be as short as 18 days!
That’s FASTER than the time lag that’s usually associated with chemo that leads to secondary cancers.
But even if your cancer doc moves quickly to address the secondary blood cancer… it’s likely he’ll just offer you the LAST thing you’re hoping for.
More chemo!
Nobody in conventional medicine is trying to stop this vicious cycle.
But you can.
If you’re diagnosed with ovarian cancer, consult an integrative oncologist to find out what your non-drug options are.
You need something that’ll IMPROVE your outcome… and EXTEND your survival…
Not SABOTAGE it.
One option may be AHCC mushroom extract… which can help train your body to make ovarian cancer DISAPPEAR.
To keeping your blood out of the cancer crosshairs,
Melissa Young
